CS logo
small CS logo
Synexus Clinical Research US, Inc

Chicago, Illinois, United States
Research and product development in Chicago, Illinois
33 N Dearborn St Ste 500, Chicago, IL 60602

About Synexus Clinical Research US, Inc


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Synexus Clinical Research US, Inc


During the past decade, Synexus Clinical Research US, Inc conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 4 clinical trials were completed, i.e. on average, 21.1% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 4 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Synexus Clinical Research US, Inc" #1 sponsor was "Eli Lilly and Company" with 10 trials, followed by "Janssen Vaccines & Prevention B.V." with 2 trials sponsored, "Rhythm Pharmaceuticals, Inc." with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Emergent BioSolutions" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Synexus Clinical Research US, Inc" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Synexus Clinical Research US, Inc


According to Clinical.Site data, the most researched conditions in "Synexus Clinical Research US, Inc" are "Chronic Low-back Pain" (3 trials), "Diabetic Peripheral Neuropathic Pain" (3 trials), "Osteoarthritis" (3 trials), "Chikungunya Virus" (1 trials) and "Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Synexus Clinical Research US, Inc" in a lesser frequency.

Clinical Trials Intervention Types at Synexus Clinical Research US, Inc


Most popular intervention types in "Synexus Clinical Research US, Inc" are "Drug" (14 trials) and "Biological" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (16 trials), "LY3016859" (3 trials), "LY3556050" (3 trials), "LY3526318" (2 trials) and "Ad26.RSV.preF-based vaccine" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Synexus Clinical Research US, Inc


The vast majority of trials in "Synexus Clinical Research US, Inc" are 19 trials for "All" genders.

Clinical Trials Status at Synexus Clinical Research US, Inc


Currently, there are NaN active trials in "Synexus Clinical Research US, Inc". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Synexus Clinical Research US, Inc, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Synexus Clinical Research US, Inc, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".